by Mette Bach Dyremose | Jun 6, 2025 | News
On 19-25 May it was European Mental Health Week – a timely opportunity to shed light on an often-overlooked challenge: the emotional strain that fertility treatments place on individuals and couples. The psychological toll includes high levels of stress, anxiety, and...
by Mette Bach Dyremose | May 28, 2025 | News
As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in...
by Mette Bach Dyremose | May 28, 2025 | News
This second event organized by ReproYoung on 22 May once again filled the auditorium with an incredibly engaged audience at Medicon Valley Alliance in Copenhagen. The topic was male and female infertility – assessment and prognostic factors – featuring two...
by Mette Bach Dyremose | Apr 30, 2025 | News
In April 2025 ReproUnion was for the first time featured in a podcast, and it was a unique opportunity to contribute to the broader debate about Denmark’s position in the global life science sector. The podcast is part of a new series inspired by the Danish Life...
by Mette Bach Dyremose | Mar 21, 2025 | News
On 4 March, one of the world’s leading reproductive medicine journals Human Reproduction published the findings from the largest existing study, to examine the link between semen quality and mortality. Based on data from nearly 80,000 men, the study finds that higher...
by Mette Bach Dyremose | Mar 18, 2025 | News
Earlier this month Dx4Life reached a milestone in fertility diagnostics, when completing a pivotal clinical trial at Reproduktionsmedicinskt Centrum (RMC). With 100 participants it will provide results on the new product’s performance – compared to classical...
